PR Newswire||March 24, 2017
The study will measure bone in-growth into the company's 3D printed bone segments.
Business Wire||March 23, 2017
Company receives investigational testing authorization from Health Canada to conduct cervical spinal cord injury study.
Bioventus||March 17, 2017
Company hopes to begin study this year.
Business Wire||March 16, 2017
The company received the first tranche of a $40 million equity financing for the first artificial meniscus.
Business Wire||March 13, 2017
Cartiva Synthetic Cartilage Implant (SCI) receives publication of 5 year clinical data.
Business Wire||March 2, 2017
Study designed to show CelGro can be used to guide and promote nerve regeneration in damaged peripheral nerves.
Cellular Biomedicine Group||February 28, 2017
Funding will support pre-clinical studies of AlloJoin, the company's stem cell-based treatment for knee osteoarthritis.
Business Wire||February 24, 2017
Multicenter study aims to compare safety and efficacy of its SpineJack device vs. balloon kyphoplasty.
Business Wire||February 6, 2017
Company poised to begin multi-site study of the system.
Business Wire||January 19, 2017
Patients demonstrated a 96 percent success rate with subjects achieving solid arthrodesis at an average of 7.3 ± 2.3 months.
Sanford Health/Sanford Research||January 5, 2017
FDA-approved study explores abdominal fat-derived stem cells to repair small and partial rotator cuff thickness tears.
University of Bristol||December 16, 2016
It is designed to enable the meniscal tear to repair itself by encouraging cell growth in the affected tissue.
Business Wire||December 15, 2016
Trial will enroll 18 patients between the ages of 18 and 85.
Business Wire||December 8, 2016
Study followed a 35 patient consecutive series for an average of 34 months.
Business Wire||November 29, 2016
Shock absorber for the knee targets patients who are seeking alternatives to joint replacement.
Sign up now to receive the free weekly newsletter, and more!